Ibex Investors LLC - BIONDVAX PHARMACEUTICALS LTD ownership

Quarter-by-quarter ownership
Ibex Investors LLC ownership history of BIONDVAX PHARMACEUTICALS LTD
ValueSharesWeighting
Q3 2020$12,603,000
+68.6%
322,413
-1.8%
6.64%
+87.0%
Q2 2020$7,473,000
+171.6%
328,475
-8.1%
3.55%
+28.0%
Q1 2020$2,751,000
-72.5%
357,240
-66.8%
2.77%
+4371.0%
Q4 2019$10,005,000
+368.0%
1,077,000
+200.0%
0.06%
-54.1%
Q3 2019$2,138,000
+3.4%
359,0000.0%0.14%
-20.1%
Q2 2019$2,068,000
+6.1%
359,0000.0%0.17%
-2.9%
Q1 2019$1,949,000
+13.8%
359,0000.0%0.17%
-37.6%
Q4 2018$1,712,000
-14.8%
359,0000.0%0.28%
-75.0%
Q3 2018$2,010,000
-16.1%
359,0000.0%1.12%
-17.8%
Q2 2018$2,395,000
+22.8%
359,0000.0%1.36%
-15.4%
Q1 2018$1,950,000
+1.4%
359,0000.0%1.61%
+43.8%
Q4 2017$1,924,000359,0001.12%
Other shareholders

There were no reported owners of BIONDVAX PHARMACEUTICALS LTD in Q3 2023.

NameSharesValueWeighting ↓
View complete list of BIONDVAX PHARMACEUTICALS LTD shareholders